{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:12:50Z","timestamp":1778947970653,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bmcl.2024.130090","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T16:18:31Z","timestamp":1735402711000},"page":"130090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synthesis and antibacterial study of anhydrotetracycline derivatives"],"prefix":"10.1016","volume":"118","author":[{"given":"Yong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karuppu","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1683-7676","authenticated-orcid":false,"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.130090_h0005","series-title":"Tetracyclines in biology, chemistry and medicine","author":"Nelson","year":"2001"},{"key":"10.1016\/j.bmcl.2024.130090_h0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.bmcl.2024.130090_h0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2011.06354.x","article-title":"The history of the tetracyclines","volume":"1241","author":"Nelson","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bmcl.2024.130090_h0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025387","article-title":"Tetracycline antibiotics and resistance","volume":"6","author":"Grossman","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bmcl.2024.130090_h0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s40828-021-00138-x","article-title":"Tetracycline antibiotics","volume":"7","author":"Ramachanderan","year":"2021","journal-title":"ChemTexts"},{"key":"10.1016\/j.bmcl.2024.130090_h0030","first-page":"773","article-title":"Tetracycline natural products: discovery, biosynthesis and engineering","volume":"20","author":"Wang","year":"2022","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.bmcl.2024.130090_h0035","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1360\/SSC-2022-0205","article-title":"Discovery, development and syntheses of tetracycline antibiotics: derivation from natural products and application for human health","volume":"53","author":"Xia","year":"2023","journal-title":"Sci Sin Chim"},{"key":"10.1016\/j.bmcl.2024.130090_h0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6976.1996.tb00251.x","article-title":"Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution","volume":"19","author":"Roberts","year":"1996","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.bmcl.2024.130090_h0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00018-009-0172-6","article-title":"The tetracycline resistome","volume":"67","author":"Thaker","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bmcl.2024.130090_h0050","article-title":"Mechanism of tetracycline resistance by ribosomal protection protein Tet(O)","volume":"4","author":"Li","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2024.130090_h0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122085","article-title":"The development of third-generation tetracycline antibiotics and new perspectives","volume":"13","author":"Rusu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bmcl.2024.130090_h0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cbpa.2016.03.011","article-title":"Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics","volume":"32","author":"Liu","year":"2016","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmcl.2024.130090_h0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","article-title":"Review of eravacycline, a novel fluorocycline antibacterial agent","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bmcl.2024.130090_h0070","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02375-19","article-title":"In vitro activity of KBP-7072, a novel third-generation tetracycline, against 531 recent geographically diverse and molecularly characterized Acinetobacter baumannii species complex isolates","volume":"64","author":"Huband","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2024.130090_h0075","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01397-21","article-title":"Activity of the novel aminomethylcycline KBP-7072 and comparators against 1,057 geographically diverse recent clinical isolates from the SENTRY surveillance program, 2019","volume":"66","author":"Huband","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2024.130090_h0080","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1002\/anie.201304691","article-title":"Total synthesis and structural revision of Viridicatumtoxin B","volume":"52","author":"Nicolaou","year":"2013","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2024.130090_h0085","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.1021\/ja506472u","article-title":"Total synthesis of Viridicatumtoxin B and analogues thereof: strategy evolution, structural revision, and biological evaluation","volume":"136","author":"Nicolaou","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2024.130090_h0090","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1021\/jacs.6b12654","article-title":"Asymmetric alkylation of anthrones, enantioselective total synthesis of (\u2212)- and (+)-Viridicatumtoxins B and analogues thereof: absolute configuration and potent antibacterial agents","volume":"139","author":"Nicolaou","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2024.130090_h0095","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3389\/fmicb.2018.01058","article-title":"Tetracycline-inactivating enzymes","volume":"9","author":"Markley","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2024.130090_h0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1021\/acsinfecdis.8b00349","article-title":"Semisynthetic analogues of anhydrotetracycline as inhibitors of tetracycline destructase enzymes","volume":"5","author":"Markley","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2024.130090_h0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s42003-020-0966-5","article-title":"Tetracycline-inactivating enzymes from environmental, human commensal, and pathogenic bacteria cause broad-spectrum tetracycline resistance","volume":"3","author":"Gasparrini","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.bmcl.2024.130090_h0110","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1021\/acs.jmedchem.2c01629","article-title":"Structure-based design of bisubstrate tetracycline destructase inhibitors that block flavin redox cycling","volume":"66","author":"Williford","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130090_h0115","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1021\/ja00723a049","article-title":"Structure of chelocardin, a novel tetracycline antibiotic","volume":"92","author":"Mitscher","year":"1970","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2024.130090_h0120","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.38.4.637","article-title":"Tetracycline analogs whose primary target is not the bacterial ribosome","volume":"38","author":"Chopra","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2024.130090_h0125","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1099\/mic.0.070995-0","article-title":"Identification of the chelocardin biosynthetic gene cluster from Amycolatopsis sulphurea: a platform for producing novel tetracycline antibiotics","volume":"159","author":"Lukezic","year":"2013","journal-title":"Microbiology"},{"key":"10.1016\/j.bmcl.2024.130090_h0130","first-page":"583","article-title":"Chelocardin, a new broad-spectrum antibiotic. I. Discovery and biological properties","author":"Oliver","year":"1962","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2024.130090_h0135","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01289-23","article-title":"Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models","volume":"12","author":"Rox","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bmcl.2024.130090_h0140","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/AAC.36.4.876","article-title":"Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes","volume":"36","author":"Oliva","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2024.130090_h0145","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01373-20","article-title":"Comparison of proteomic responses as a global approach to antibiotic mechanism of action elucidation","volume":"65","author":"Senges","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2024.130090_h0150","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/acschembio.8b01125","article-title":"Engineering atypical tetracycline formation in Amycolatopsis sulphurea for the production of modified chelocardin antibiotics","volume":"14","author":"Lukezic","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2024.130090_h0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12934-020-01495-x","article-title":"Heterologous expression of the atypical tetracycline chelocardin reveals the full set of genes required for its biosynthesis","volume":"19","author":"Lukezic","year":"2020","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.bmcl.2024.130090_h0160","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1002\/anie.201411028","article-title":"Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering","volume":"54","author":"Lesnik","year":"2015","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2024.130090_h0165","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202306437","article-title":"Revision of the absolute configurations of chelocardin and amidochelocardin","volume":"62","author":"Sikandar","year":"2023","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2024.130090_h0170","doi-asserted-by":"crossref","first-page":"112005","DOI":"10.1016\/j.ejmech.2019.112005","article-title":"Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibiotics","volume":"188","author":"Grandclaudon","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130090_h0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bbapap.2016.03.004","article-title":"Dual mechanism of action of the atypical tetracycline chelocardin","volume":"1864","author":"Stepanek","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmcl.2024.130090_h0180","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/antibiotics9090619","article-title":"Amidochelocardin overcomes resistance mechanisms exerted on tetracyclines and natural chelocardin","volume":"9","author":"Hennessen","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmcl.2024.130090_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2023.154829","article-title":"Study for C4-O-glycosylation of tetracycline","volume":"133","author":"Wu","year":"2023","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2024.130090_h0190","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/ja01067a055","article-title":"Novel C-4 modified tetracycline derivatives","volume":"86","author":"Blackwood","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2024.130090_h0195","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1021\/ja01072a056","article-title":"A new class of tetracycline derivatives","volume":"86","author":"Esse","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2024.130090_h0200","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1021\/ja01072a057","article-title":"Tetracycloxides II. Transformations at the C-4 position","volume":"86","author":"Esse","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2024.130090_h0205","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1139\/v65-187","article-title":"Some transformations of tetracycline at the 4-position","volume":"43","author":"Blackwood","year":"1965","journal-title":"Can J Chem"},{"key":"#cr-split#-10.1016\/j.bmcl.2024.130090_b0065.1","doi-asserted-by":"crossref","unstructured":"For the reduction: (a) Luche JL, Rodriguez-Hahn L, Crabbe P. Reduction of natural enones in the presence of cerium trichloride. J Chem Soc, Chem Commun 1978;14:601-2","DOI":"10.1039\/C39780000601"},{"key":"#cr-split#-10.1016\/j.bmcl.2024.130090_b0065.2","doi-asserted-by":"crossref","unstructured":"(b) Luche JL. Lanthanides in organic chemistry. 1. Selective 1,2 reductions of conjugated ketones. J Am Chem Soc 1978;100:2226-7","DOI":"10.1021\/ja00475a040"},{"key":"#cr-split#-10.1016\/j.bmcl.2024.130090_b0065.3","doi-asserted-by":"crossref","unstructured":"(c) Maruoka K, Yamamoto H. Selective reactions using organoaluminum reagents [new synthetic methods (54)]. Angew Chem Int Ed Engl 1985;24:668-82","DOI":"10.1002\/anie.198506681"},{"key":"#cr-split#-10.1016\/j.bmcl.2024.130090_b0065.4","doi-asserted-by":"crossref","unstructured":"(d) Corey EJ, Bakshi RK, Shibata S. Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. Mechanism and synthetic implications. J Am Chem Soc 1987;109:5551-3","DOI":"10.1021\/ja00252a056"},{"key":"#cr-split#-10.1016\/j.bmcl.2024.130090_b0065.5","doi-asserted-by":"crossref","unstructured":"(e) Owsianik K, Krawczyk E, Mielniczak G, Koprowski M, Siero\u0144 L. Three-step synthesis of chiral and sterically hindered amino alcohols based on cyclic enol phosphates. Tetrahedron 2018;74:7343-50","DOI":"10.1016\/j.tet.2018.10.072"},{"key":"#cr-split#-10.1016\/j.bmcl.2024.130090_b0065.6","doi-asserted-by":"crossref","unstructured":"(f) Ribeiro JLP, Alves C, Cardoso AL, Lopes SMM, Pinho e Melo TMVD. Reduction of oximes and hydrazones: asymmetric and diastereoselective approaches. Curr Org Chem. 2021;25:2175-98.","DOI":"10.2174\/1385272825666210706151631"},{"key":"10.1016\/j.bmcl.2024.130090_h0215","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/ja01086a035","article-title":"4-Hydroxy-6-methylpretetramid. Synthesis via quaternary tetracyclines","volume":"87","author":"Hlavka","year":"1965","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2024.130090_h0220","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1039\/c39770000790","article-title":"Reaction of tetracycline hydrochloride with N-chlorosuccinimide: X-ray crystal structure of the major product","author":"Barton","year":"1977","journal-title":"J Chem Soc Chem Commun"},{"key":"10.1016\/j.bmcl.2024.130090_h0225","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1021\/ja01500a038","article-title":"Chemistry of the tetracycline antibiotics. II. Bromination of dedimethylamino tetracyclines","volume":"82","author":"Green","year":"1960","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2024.130090_h0230","first-page":"357","article-title":"Bromination of tetracycline","volume":"45","author":"Bilovic","year":"1973","journal-title":"Croat Chem Acta"},{"key":"10.1016\/j.bmcl.2024.130090_h0235","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1021\/jo030047d","article-title":"Versatile and facile synthesis of diverse semisynthetic tetracycline derivatives via Pd-catalyzed reactions","volume":"68","author":"Nelson","year":"2003","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2024.130090_h0240","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/cbic.200600226","article-title":"Subtype selective tetracycline agonists and their application for a two-stage regulatory system","volume":"7","author":"Berens","year":"2006","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmcl.2024.130090_h0245","doi-asserted-by":"crossref","first-page":"13553","DOI":"10.1002\/chem.201502113","article-title":"Total synthesis of antitumor antibiotic derhodinosylurdamycin A","volume":"21","author":"Khatri","year":"2015","journal-title":"Chem Eur J"},{"key":"10.1016\/j.bmcl.2024.130090_h0250","article-title":"C9-functionalized doxycycline analogs as drug candidates to prevent pathological \u03b1-synuclein aggregation and neuroinflammation in Parkinson's disease degeneration","volume":"19","author":"Cl\u00e9mence","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2024.130090_h0255","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/ja01489a064","article-title":"Further 6-deoxytetracycline studies: effect of aromatic substituents on biological activity","volume":"82","author":"Beereboom","year":"1960","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2024.130090_h0260","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1021\/jm00313a009","article-title":"The 6-Deoxytetracyclines. VII. Alkylated aminotetracyclines possessing unique antibacterial activity","volume":"10","author":"Martell","year":"1967","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130090_h0265","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1021\/jo00804a025","article-title":"Synthesis of 7-dimethylamino-6-demethyl-6- deoxytetracycline (minocycline) via 9-nitro-6-demethyl-6- deoxytetracycline","volume":"36","author":"Church","year":"1971","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2024.130090_h0270","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0960-894X(02)00369-4","article-title":"Synthesis and biological evaluation of 9-substituted tetracycline derivatives","volume":"12","author":"Koza","year":"2002","journal-title":"Biorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.130090_h0275","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bmcl.2005.09.078","article-title":"Synthesis and antibacterial activity of 9-substituted minocycline derivatives","volume":"16","author":"Sum","year":"2006","journal-title":"Biorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.130090_h0280","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/np4003096","article-title":"Synthesis and antibacterial activity of doxycycline neoglycosides","volume":"76","author":"Zhang","year":"2013","journal-title":"J Nat Prod"},{"key":"#cr-split#-10.1016\/j.bmcl.2024.130090_b0085.1","doi-asserted-by":"crossref","unstructured":"For the biological test, see: (a) Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001;48:5-16","DOI":"10.1093\/jac\/48.suppl_1.5"},{"key":"#cr-split#-10.1016\/j.bmcl.2024.130090_b0085.2","doi-asserted-by":"crossref","unstructured":"(b) for MIC value test review, see: Kowalska-Krochmal B, Dudek-Wicher R. The minimum inhibitory concentration of antibiotics: Methods, interpretation, clinical relevance. Pathogens 2021;10:165.","DOI":"10.3390\/pathogens10020165"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2400492X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2400492X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T03:38:32Z","timestamp":1740454712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2400492X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":63,"alternative-id":["S0960894X2400492X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.130090","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and antibacterial study of anhydrotetracycline derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.130090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130090"}}